BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
51 hedge funds and large institutions have $17.2M invested in BRAINSTORM CELL THERAPUTC in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 1 reducing their positions, and 7 closing their positions.
Holders
51
Holders Change
+7
Holders Change %
+15.91%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
21
Reduced
1
Closed
7
Calls
$3.72M
Puts
$3.41M
Net Calls
+$311K
Net Calls Change
+$1.44M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$5.64M |
2 |
2
Renaissance Technologies
New York
|
$2.68M |
3 |
3
BlackRock
New York
|
$1.78M |
4 |
4
Millennium Management
New York
|
$919K |
5 |
EI
5
EAM Investors
Solana Beach,
California
|
$603K |